EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens

Debora Inacio Leite, Stefany de Castro Bazan Moura, Maria da Conceição Avelino Dias iD, Carolina Catta Preta Costa, Gustavo Peixoto Machado, Luiz Claudio Ferreira Pimentel iD, Frederico Silva Castelo Branco, Rui Moreira iD, Monica Macedo Bastos, Nubia Boechat

Molecules · 2023

DOI: 10.3390/molecules28083342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Debora Inacio Leite und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Sintese de Farmacos (LASFAR), Fundacao Oswaldo Cruz, Instituto de Tecnologia em Farmacos (Farmanguinhos), Fiocruz, Rua Sizenando Nabuc…. Hauptthemen laut MEDLINE: Coinfection, Tuberculosis, Mycobacterium tuberculosis, HIV Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human immunodeficiency virus (HIV) produces the pathologic basis of acquired immunodeficiency syndrome (AIDS). An increase in the viral load in the body leads to a decline in the number of T lymphocytes, compromising the patient’s immune system. Some opportunistic diseases may result, such as tuberculosis (TB), which is the most common in seropositive patients. Long-term treatment is required for HIV-TB coinfection, and cocktails of drugs for both diseases are used concomitantly. The most challenging aspects of treatment are the occurrence of drug interactions, overlapping toxicity, no adherence to treatment and cases of resistance. Recent approaches have involved using molecules that can act synergistically on two or more distinct targets. The development of multitarget molecules could overcome the disadvantages of the therapies used to treat HIV-TB coinfection. This report is the first review on using molecules with activities against HIV and Mycobacterium tuberculosis (MTB) for molecular hybridization and multitarget strategies. Here, we discuss the importance and development of multiple targets as a means of improving adherence to therapy in cases of the coexistence of these pathologies. In this context, several studies on the development of structural entities to treat HIV-TB simultaneously are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoinfectionTuberculosisMycobacterium tuberculosisHIV InfectionsHumansHIVAntitubercular Agents

Stichwörter der Autor:innen

AIDSHIVcoinfectionhybridmultitargettuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Laboratorio de Sintese de Farmacos (LASFAR), Fundacao Oswaldo Cruz, Instituto de Tecnologia em Farmacos (Farmanguinhos), Fiocruz, Rua Sizenando Nabuco, 100 Manguinhos, Rio de Janeiro 21041-000, Brazil.
  • Programa de Pos-Graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biomédicas (ICB), Universidade Federal do Rio de Janeiro (UFRJ), Av. Carlos Chagas Filho, Rio de Janeiro 21941-902, Brazil.
  • Departamento de Química Medicinal, Faculdade de Farmácia, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.

ORCID-Profile: Maria da Conceição Avelino Dias, Luiz Claudio Ferreira Pimentel, Rui Moreira

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil
  • National Council of R&D of Brazil
  • National Council for Scientific and Technological Development—CNPq
  • PROEP-CNPq
  • Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro—FAPERJ
  • Programe Inova-Fiocruz

Zitieren

APA

Leite, D. I., de Castro Bazan Moura, S., da Conceição Avelino Dias, M., Costa, C. C. P., Machado, G. P., Pimentel, L. C. F., Branco, F. S. C., Moreira, R., Bastos, M. M., & Boechat, N. (2023). A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens. Molecules. https://doi.org/10.3390/molecules28083342

Vancouver

Leite DI, de Castro Bazan Moura S, da Conceição Avelino Dias M, Costa CCP, Machado GP, Pimentel LCF, et al. A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens. Molecules. 2023. doi:10.3390/molecules28083342

BibTeX
@article{Leite2023,
  author = {Leite, Debora Inacio and de Castro Bazan Moura, Stefany and da Conceição Avelino Dias, Maria and Costa, Carolina Catta Preta and Machado, Gustavo Peixoto and Pimentel, Luiz Claudio Ferreira and Branco, Frederico Silva Castelo and Moreira, Rui and Bastos, Monica Macedo and Boechat, Nubia},
  title = {A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28083342}
}
Kostenlos starten →